<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Secondary hyperfibrinolysis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Secondary hyperfibrinolysis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Secondary hyperfibrinolysis</div><div class="cntnt"><img src="data:jpeg;base64,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"/></div><div class="graphic_lgnd">Citrated rapid thromboelastography study (rapid-TEG) showing secondary hyperfibrinolysis. The red tracing indicates a normal study.<br/>This study shows a normal ACT, R time, K time, and alpha angle; high LY30 reflecting hyperfibrinolysis; and normal MA and G, reflecting onset of fibrinolysis after achieving maximal clot strength.</div><div class="graphic_footnotes">R (reaction time): time from sample placement or activation until the tracing amplitude reaches 2 mm; K (clot formation time): time elapsed between the R-time and the point where the tracing amplitude reaches 20 mm; alpha angle: angle between the middle line of the tracing and a tangential line to the developing "body" of the tracing; MA (maximal amplitude): the maximal amplitude reached after clot initiation; G: a calculated measure of total clot strength based on amplitude; LY30: the amount of clot lysis detected 30 minutes after the maximal amplitude (MA) is reached; SP (split point): time from sample placement (or activation with an exogenous procoagulant) until the earliest detectable resistance.</div><div id="graphicVersion">Graphic 70388 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
